Sobre nós Contatos Interações: 118 620
Pesquisa de medicamentos por nome

Sodium Sulfacetamide Sulfur Cleansing Cloths e Disfunção renal

Resultado da verificação da interação do medicamento Sodium Sulfacetamide Sulfur Cleansing Cloths com doença Disfunção renal quanto a segurança no uso em conjunto.

Resultado da verificação:
Sodium Sulfacetamide Sulfur Cleansing Cloths <> Disfunção renal
Relevância: 23.07.2019 Revisor: Shkutko P.M., M.D., in

Na verificação da interação, conforme informações das fontes confiáveis como Drugs.com, Rxlist.com, Webmd.com, Medscape.com, foram identificadas as contra-indicações ou efeitos colaterais que podem prejudicar a saúde ou aumentar efeito negativo ao consumir o medicamento com esta doença concomitante.

Consumidor:

Sulfonamidas pode ser absorvido sistemicamente, quando aplicado à pele, olhos ou membranas mucosas. Uma vez absorvido, sulfonamidas e seus metabólitos são eliminados pelo rim. Pacientes com insuficiência renal podem estar em maior risco de efeitos adversos de sulfonamidas devido à diminuição da droga folga. Além disso, sulfonamidas podem causar toxicidade renal secundária a crystalluria, incluindo uro - e nefrolitíase, nefrite, tóxicos nephrosis, hematúria, proteinúria e, elevados BUN e creatinina. Hidratação adequada e de débito urinário (> 1,5 L/dia) deve ser mantida durante a sulfonamida de administração. Testes de função Renal e exame de urina deve ser realizado regularmente durante terapia prolongada (> 2 semanas). Alguns fabricantes tópica de sulfonamida produtos não recomendamos seu uso em pacientes com comprometimento da função renal.

Referências
  • Cohen M, Pocelinko R "Renal transport mechanisms for the excretion of sulfisoxazole." J Pharmacol Exp Ther 185 (1973): 703-12
  • "Product Information. Azopt (brinzolamide ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
  • Christin S, Baumelou A, Bahri S, Ben Hmida M, Deray G, Jacobs C "Acute renal failure due to sulfadiazine in patients with AIDS." Nephron 55 (1990): 233-4
  • Simon D, Brosius F, Rothstein D "Sulfadiazine crystalluria revisited." Arch Intern Med 150 (1990): 2379-84
  • Madsen S "A comparative study of the excretion of sulfonamide-metabolites in cases of renal failure and hepatitis." Chemotherapy 11 (1966): 1-9
  • Hein R, Brunkhorst R, Thon WF, Schedel I, Schmidt RE "Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases." Clin Nephrol 39 (1993): 254-6
  • Ohnhaus EE, Spring P "Elimination kinetics of sulfadiazine in patients with normal and impaired renal function." J Pharmacokinet Biopharm 3 (1975): 171-9
  • Marques L, Silva M, Madeira E, Santos O "Obstructive renal failure due to therapy with sulfadiazine in an AIDS patient." Nephron 62 (1992): 361
  • Hekster C, Vree T "Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives." Antibiot Chemother 31 (1982): 22-118
  • Rieder J, Schwartz DE, Fernex M, et al "Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function." Antibiot Chemother 18 (1974): 148-98
  • "Product Information. Klaron (sulfacetamide sodium topical)." Dermik Laboratories, Collegeville, PA.
  • Shermantine M, Gambertoglio J, Amend W, Vincenti F, Oie S "Pharmacokinetics of sulfisoxazole in renal transplant patients." Antimicrob Agents Chemother 28 (1985): 535-9
  • Sahai J, Heimberger R, Collins K, Kaplowitz L, Polk R "Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome: a reminder." Am J Med 84 (1988): 791-2
  • Carbone L, Bendixen B, Appel G "Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome." Am J Kidney Dis 12 (1988): 72-5
  • Patel RB, Welling PG "Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole)." Clin Pharmacokinet 5 (1980): 405-23
  • Marques LP, Silva MT, Madeira EP, Santos OR "Obstructive renal failure due to therapy with sulfadiazine in an AIDS patient." Nephron 62 (1992): 361
  • Kremers P, Duvivier J, Heusghem C "Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses." J Clin Pharmacol 14 (1974): 112-7
  • Bergan T, Brodwall EK, Vik-Mo H, Anstad U "Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function." Infection 7 (1979): s382-7
  • "Product Information. AVC Cream (sulfanilamide topical)" Aventis Pharmaceuticals, Swiftwater, PA.
  • Ortengren B, Fellner H, Bergan T "Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides." Infection 7 Suppl 4 (1979): s367-70
  • "Product Information. Gantrisin (sulfisoxazole ophthalmic)." Roche Laboratories, Nutley, NJ.
  • Bergan T, Brodwall E, Vik-Mo H, Anstad U "Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function." Infection 7 (1979): s382-7
  • Goadsby P, Donaghy A, Lloyd A, Wakefield D "Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure." Ann Intern Med 107 (1987): 783-4
  • "Product Information. Sulamyd Ophthalmic Solution (sodium sulfacetamide ophthalmic)." Schering Corporation, Kenilworth, NJ.
  • Bergan T, Brodwall EK "Human pharmacokinetics of a sulfamethoxazole-trimethoprim combination." Acta Med Scand 192 (1972): 483-92
  • "Product Information. Sultrin (triple sulfa topical)" Janssen Pharmaceuticals, Titusville, NJ.
  • Adam WR, Henning M, Dawborn JK "Excretion of trimethoprim and sulphamethoxazole in patients with renal failure." Aust N Z J Med 3 (1973): 383-7
  • Andreasen F, Elsborg L, Husted S, Thomsen O "Pharmacokinetics of sulfadiazine and trimethoprim in man." Eur J Clin Pharmacol 14 (1978): 57-67
  • Molina J, Belenfant X, Doco-Lecompte T, et al "Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis." AIDS 5 (1991): 587-9
  • Rudra T, Webb D, Evans A "Acute tubular necrosis following co-trimoxazole therapy." Nephron 53 (1989): 85-6
  • Sasson JP, Dratch PL, Shortsleeve MJ "Renal US findings in sulfadiazine-induced crystalluria." Radiology 185 (1992): 739-40
  • Cryst C, Hammar S "Acute granulomatous interstitial nephritis due to co-trimoxazole." Am J Nephrol 8 (1988): 483-8
  • "Product Information. Sulfacet-R (sulfacetamide sodium topical)" Dermik Laboratories, Collegeville, PA.
  • Becker K, Jablonowski H, Haussinger D "Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome." Medicine 75 (1996): 185-94
  • "Product Information. Trusopt (dorzolamide ophthalmic)." Merck & Co, Inc, West Point, PA.
  • Adam W, Dawborn J "Urinary excretion and plasma levels of sulphonamides in patients with renal impairment." Australas Ann Med 19 (1970): 250-4
  • Robson M, Levi J, Dolberg L, Rosenfeld J "Acute tubulo-interstitial nephritis following sulfadiazine therapy." Isr J Med Sci 6 (1970): 561-6
  • Ortengren B, Magni L, Bergan T "Development of sulphonamide-trimethoprim combinations for urinary tract infections. part 3: pharmacokinetic characterization of sulphadiazine and sulphamethoxazole." Infection 7 (1979): s371-81
  • Stachowska B, Senczuk W "Studies on kinetics of sulfadiazine and trimethoprim excretion in man." Int J Clin Pharmacol Ther Toxicol 25 (1987): 81-5
  • Erturk E, Casemento JB, Guertin KR, Kende AS "Bilateral acetylsulfapyridine nephrolithiasis associated with chronic sulfasalazine therapy." J Urol 151 (1994): 1605-6
  • Vergin H, Ferber H, Zimmermann I, Neurath GB "Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients." Int J Clin Pharmacol Ther Toxicol 19 (1981): 350-7
  • Farinas MC, Echevarria S, Sampedro I, Gonzalez A, Perez del Molino A, Gonzalez-Macias J "Renal failure due to sulphadiazine in AIDS patients with cerebral toxoplasmosis." J Intern Med 233 (1993): 365-7
  • Dwarakanath AD, Michael J, Allan RN "Sulphasalazine-induced renal failure." Gut 33 (1992): 1006-7
  • Smith E, Light J, Filo R, Yum M "Interstitial nephritis caused by trimethoprim-sulfamethoxazole in renal transplant recipients." JAMA 244 (1980): 360-1
Sodium Sulfacetamide Sulfur Cleansing Cloths

Nome genérico: sulfacetamide sodium / sulfur topical

Marca comercial: Avar, BP 10-Wash, Clarifoam EF, Garimide, Plexion, Prascion Cleanser, Rosanil Cleanser, Rosula, Sulfacleans 8/4, Sumadan, Sumaxin, Suphera, Virti-Sulf, Zencia Wash, Novacet, Sulfacet-R, Zetacet, Plexion Cleanser, Plexion TS, Rosula Cleanser, Nicosyn, Avar Cleanser, Clenia Foaming Wash, Clenia Emollient Cream, Avar Gel, Avar Green, Rosac, Avar-E Emollient, Avar-E Green, Rosaderm Cleanser, Zetacet Wash, Plexion SCT, Plexion Cleansing Cloths, Sulfatol, Sulfatol Cleanser, Prascion FC Cloths, Prascion RA, Rosula Clarifying Wash, Prascion, Rosac Wash, Topisulf, Sulfatol C, SulZee Wash, Sulfatol SS, Sumaxin Wash, Avar LS Cleanser, Avar-e LS, SE 10-5 SS, Avar-E, Sumaxin TS, Sumadan Wash, Sumaxin CP, Avar LS, Sumadan XLT, Rosula Wash, SSS 10-4, SSS 10-5

Sinônimos: Sulfacetamide sodium and sulfur topical, Sulfur and Sulfacetamide

O que é Sodium Sulfacetamide Sulfur Cleansing Cloths?
Outro medicamento Eliminar
Lista de interações populares
DiseDoc Mundo
Interação entre medicamento, comida e estilo de vida
  1. Sodium Sulfacetamide Sulfur Cleansing Cloths
Interações medicamentosas
  1. Sodium Sulfacetamide Sulfur Cleansing Cloths
Usamos cookies para melhorar o funcionamento do site. Ao continuar, você concorda com o uso de cookies. OK